Surveillance of adverse events following immunization in China: Past, present, and future
- PMID: 25936727
- DOI: 10.1016/j.vaccine.2015.04.060
Surveillance of adverse events following immunization in China: Past, present, and future
Abstract
Surveillance for adverse events following immunization (AEFI) is an important component of any national immunization program. In the People's Republic of China (China), a populous, middle-income country, development of an AEFI surveillance system began in 2005. In 2008, the AEFI surveillance system was implemented as a nationwide, online system and called the Chinese National AEFI Information System (CNAEFIS). Since then, CNAEFIS has provided useful, national-level data on vaccine safety. National AEFI surveillance guidelines were issued jointly by the Ministry of Health and the China Food and Drug Administration in 2010. This article reviews the development, status, and key aspects of the Chinese AEFI surveillance system, and describes challenges and future plans for vaccine safety assessment in China.
Keywords: Adverse events following immunization (AEFI); Surveillance; Vaccination.
Copyright © 2015. Published by Elsevier Ltd.
Similar articles
-
Active surveillance for adverse events following immunization.Expert Rev Vaccines. 2014 Feb;13(2):265-76. doi: 10.1586/14760584.2014.866895. Epub 2013 Dec 18. Expert Rev Vaccines. 2014. PMID: 24350637 Review.
-
Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.Vaccine. 2019 Feb 21;37(9):1182-1187. doi: 10.1016/j.vaccine.2019.01.009. Epub 2019 Jan 29. Vaccine. 2019. PMID: 30709723
-
Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.Indian J Pediatr. 2018 Feb;85(2):139-148. doi: 10.1007/s12098-017-2532-9. Epub 2017 Nov 23. Indian J Pediatr. 2018. PMID: 29170922 Review.
-
Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021.Hum Vaccin Immunother. 2023 Aug;19(2):2263225. doi: 10.1080/21645515.2023.2263225. Epub 2023 Oct 2. Hum Vaccin Immunother. 2023. PMID: 37782096 Free PMC article.
-
Adverse events following immunization: is this time for the use of WHO causality assessment?Expert Rev Vaccines. 2015 May;14(5):625-7. doi: 10.1586/14760584.2015.1029460. Epub 2015 Mar 25. Expert Rev Vaccines. 2015. PMID: 25805053
Cited by
-
Hepatitis A vaccination.Hum Vaccin Immunother. 2020 Jul 2;16(7):1565-1573. doi: 10.1080/21645515.2020.1769389. Epub 2020 Jul 10. Hum Vaccin Immunother. 2020. PMID: 32649265 Free PMC article.
-
Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.Front Immunol. 2022 Sep 30;13:956473. doi: 10.3389/fimmu.2022.956473. eCollection 2022. Front Immunol. 2022. PMID: 36248783 Free PMC article.
-
The vaccines-associated Arthus reaction.Hum Vaccin Immunother. 2019;15(11):2769-2777. doi: 10.1080/21645515.2019.1602435. Epub 2019 May 3. Hum Vaccin Immunother. 2019. PMID: 30945978 Free PMC article. Review.
-
Pharmacovigilance in China: Evolution and future challenges.Br J Clin Pharmacol. 2023 Feb;89(2):510-522. doi: 10.1111/bcp.15277. Epub 2022 Mar 16. Br J Clin Pharmacol. 2023. PMID: 35165914 Free PMC article. Review.
-
Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China.Hum Vaccin Immunother. 2022 Dec 31;18(1):2035141. doi: 10.1080/21645515.2022.2035141. Epub 2022 Mar 3. Hum Vaccin Immunother. 2022. PMID: 35240930 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous